Dr. Rohan Reddy Katipally, MD

Dr. Katipally practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Dr. Katipally's NPI, 1689168205, was assigned on June 18, 2018. Dr. Katipally holds Illinois license 036.165345.

Dr. Katipally's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Katipally's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dr. Katipally is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Katipally to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katipally practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Katipally's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Katipally is licensed in Illinois.

CMS data shows 1,970 Medicare services from Dr. Katipally across 14 procedure codes in 2024, for 206 Medicare patients. Medicare paid $137,853 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 206 Medicare patients who saw Dr. Katipally in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katipally's median patient age at 70, with 33% women.

In 2024, Dr. Katipally wrote 60 Medicare Part D claims for 38 patients. 90% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $360 in total drug cost.

Dr. Katipally accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katipally as offering telehealth.

Dmand AI links 29 papers to Dr. Katipally, published from 2014 to 2025. 2025 was the busiest year, with 6. The most frequent topics are Radiosurgery, Immune Checkpoint Inhibitors and Liver Neoplasms. Dr. Katipally has published most often in Int J Radiat Oncol Biol Phys. Dr. Katipally's most frequent co-authors are Sean Pravin Pitroda, MD, Aditya Juloori, MD and Ralph R. Weichselbaum, MD.

CMS Open Payments shows 15 general payments to Dr. Katipally from 5 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $381.